BAYN Bayer Aktiengesellschaft
Stock · XETRA · Germany · Healthcare · DE000BAY0017
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bayer Aktiengesellschaft, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
56.82 EUR
+0.46%
52-week range
26.64 – 57.78
Dividend yield0.19%
Market cap55.8B
NowoTrade score
9 Grade A
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 09:50. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
24 Feb 2027
in 103 days · 11:00 · estimate 0.60
Last results
0.31 vs 0.28 estimated
28 Oct 2026 · Beat +12.7%
Beat the estimate
9 of 12
3 missed · 0 in line · 7 beats in a row
Average surprise
+21.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 11:00 | 0.60 | — | — | Upcoming |
| 28 Oct 2026 20:00 | 0.28 | 0.31 | +12.7% | Beat |
| 31 Jul 2026 07:00 | 0.75 | 0.95 | +27.3% | Beat |
| 11 May 2026 20:00 | 2.25 | 2.71 | +20.6% | Beat |
| 03 Mar 2026 19:00 | 0.49 | 0.62 | +27.0% | Beat |
| 11 Nov 2025 18:00 | 0.32 | 0.57 | +75.5% | Beat |
| 06 Aug 2025 01:00 | 0.79 | 1.23 | +56.3% | Beat |
| 13 May 2025 01:00 | 2.28 | 2.49 | +9.1% | Beat |
| 04 Mar 2025 18:00 | 1.09 | 1.05 | -3.3% | Miss |
| 12 Nov 2024 05:00 | 0.32 | 0.24 | -24.4% | Miss |
| 06 Aug 2024 01:00 | 0.96 | 0.94 | -2.2% | Miss |
| 14 May 2024 05:00 | 2.29 | 2.82 | +23.3% | Beat |
| 04 Mar 2024 21:00 | 1.42 | 1.85 | +30.7% | Beat |
| 08 Nov 2023 02:00 | 0.76 | 0.38 | -49.8% | Miss |
| 08 Aug 2023 04:00 | 1.23 | 1.22 | -0.4% | In line |
| 11 May 2023 09:00 | 2.78 | 2.95 | +6.2% | Beat |
| 28 Feb 2023 04:00 | 1.25 | 1.35 | +8.3% | Beat |
| 08 Nov 2022 01:00 | 1.18 | 1.13 | -3.9% | Miss |
| 04 Aug 2022 01:00 | 1.85 | 1.93 | +4.5% | Beat |
| 10 May 2022 01:00 | 2.96 | 3.53 | +19.3% | Beat |
| 01 Mar 2022 02:00 | 1.00 | 1.26 | +26.4% | Beat |
| 09 Nov 2021 08:00 | 0.90 | 1.05 | +17.2% | Beat |
| 05 Aug 2021 09:00 | 1.54 | 1.61 | +4.6% | Beat |
| 12 May 2021 03:00 | 2.35 | 2.59 | +10.2% | Beat |
| 25 Feb 2021 02:00 | 1.24 | 1.32 | +6.4% | Beat |
| 03 Nov 2020 01:00 | 0.92 | 0.81 | -12.3% | Miss |
| 04 Aug 2020 03:00 | 1.51 | 1.59 | +5.4% | Beat |
| 27 Apr 2020 03:00 | 2.62 | 2.67 | +1.9% | Beat |
| 27 Feb 2020 05:00 | 1.23 | 1.29 | +4.8% | Beat |
| 30 Oct 2019 02:00 | 1.17 | 1.16 | -0.6% | In line |
| 30 Jul 2019 02:00 | 1.74 | 1.62 | -6.7% | Miss |
| 25 Apr 2019 01:00 | 2.47 | 2.55 | +3.2% | Beat |
| 27 Feb 2019 01:00 | 0.87 | 1.10 | +27.1% | Beat |
| 13 Nov 2018 01:00 | 1.05 | 1.19 | +13.2% | Beat |
| 05 Sep 2018 01:00 | 1.55 | 1.54 | -0.7% | In line |
| 03 May 2018 01:00 | 2.08 | 2.28 | +9.6% | Beat |
| 28 Feb 2018 01:00 | 1.12 | 1.41 | +26.4% | Beat |
| 26 Oct 2017 01:00 | 1.34 | 1.47 | +10.0% | Beat |
| 27 Jul 2017 01:00 | 1.78 | 1.81 | +1.5% | Beat |
| 27 Apr 2017 01:00 | 2.46 | 2.62 | +6.4% | Beat |
| 22 Feb 2017 01:00 | 1.24 | 1.19 | -4.2% | Miss |
| 26 Oct 2016 01:00 | 1.66 | 1.73 | +4.4% | Beat |
| 27 Jul 2016 01:00 | 2.01 | 2.07 | +3.0% | Beat |
| 26 Apr 2016 01:00 | 2.18 | 2.37 | +8.9% | Beat |
| 25 Feb 2016 01:00 | 1.26 | 1.08 | -14.4% | Miss |
| 29 Oct 2015 02:00 | 1.46 | 1.72 | +17.4% | Beat |
| 29 Jul 2015 01:00 | 1.84 | 2.00 | +8.9% | Beat |
| 30 Apr 2015 01:00 | 2.13 | 2.10 | -1.4% | Miss |
| 26 Feb 2015 01:00 | 1.18 | 1.19 | +0.5% | In line |
| 30 Oct 2014 02:00 | 1.26 | 1.35 | +7.2% | Beat |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 45.6B | -2.2% | -3.6B | -7.9% | -3.68 | -41.5% | 3.4B |
| 2024 | 46.6B | -2.2% | -2.6B | -5.5% | -2.60 | +13.0% | 4.6B |
| 2023 | 47.6B | -6.1% | -2.9B | -6.2% | -2.99 | -170.9% | 2.4B |
| 2022 | 50.7B | — | 4.2B | 8.2% | 4.22 | — | 4.1B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 49.92 | 57.84 | 49.49 | 56.82 | +12.34% | 33,261,752 | |
| Oct 2026 | 47.31 | 50.66 | 42.56 | 50.58 | +5.48% | 48,994,224 | |
| Sep 2026 | 49.41 | 51.00 | 47.63 | 47.95 | -2.22% | 48,418,629 | |
| Aug 2026 | 48.14 | 50.50 | 46.96 | 49.04 | +2.06% | 41,611,084 | |
| Jul 2026 | 48.50 | 53.92 | 45.49 | 48.05 | -0.74% | 59,268,629 | |
| Jun 2026 | 36.40 | 48.41 | 32.96 | 48.41 | +32.52% | 88,185,285 | |
| May 2026 | 38.11 | 39.65 | 35.95 | 36.53 | -3.99% | 49,238,201 | |
| Apr 2026 | 39.79 | 41.77 | 35.89 | 38.05 | -3.39% | 50,230,288 | 0.1100 |
| Mar 2026 | 40.67 | 41.39 | 35.20 | 39.38 | -6.25% | 86,088,230 | |
| Feb 2026 | 44.17 | 49.78 | 41.24 | 42.01 | -5.72% | 71,481,212 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Bayer Wins FDA Approval for Sunharbo for Secondary Stroke Risk Reduction (opens in a new tab) Zacks · 10 Nov 2026 18:39
- Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer (opens in a new tab) Zacks · 10 Nov 2026 05:50
- Are Medical Stocks Lagging Bayer (BAYRY) This Year? (opens in a new tab) Zacks · 05 Nov 2026 13:40
- Bayer (XTRA:BAYN) Stock May Still Offer Value Despite NUBEQA Trial News (opens in a new tab) Simply Wall St. · 05 Nov 2026 03:20
- What Is Bayer (XTRA:BAYN) Telling Investors With Its Higher 2026 Profit Forecast? (opens in a new tab) Simply Wall St. · 04 Nov 2026 20:16
- Bayer AG (BAYRY) (Q3 2026) Earnings Call Highlights: Raised Full-Year Outlook on Pharma ... (opens in a new tab) GuruFocus.com · 03 Nov 2026 21:05
- Bayer’s Comeback Is Starting to Look Like More Than a Lawsuit Story (opens in a new tab) Moby · 03 Nov 2026 17:10
- What Bayer Aktiengesellschaft (BAYN) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 03 Nov 2026 13:12
- Roundup settlement expected before Christmas, Bayer CEO says (opens in a new tab) Reuters · 03 Nov 2026 10:50
- Bayer Shares Jump After Pharma Recovery Prompts Outlook Raise (opens in a new tab) The Wall Street Journal · 03 Nov 2026 09:15
- Bayer shares jump 5% as Q3 beat prompts 2026 forecast upgrade (opens in a new tab) Investing.com · 03 Nov 2026 07:26
- Bayer Raises Profit Outlook Helped by Strong Demand for Drugs (opens in a new tab) Bloomberg · 03 Nov 2026 06:44
- Bayer (XTRA:BAYN) Reaches First Milestone Payment In Crop Biocontrol Partnership (opens in a new tab) Simply Wall St. · 31 Oct 2026 14:11
- Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling (opens in a new tab) Reuters · 30 Oct 2026 19:14
- Is Bayer (XTRA:BAYN) Undervalued Following Its Roundup Court Win? (opens in a new tab) Simply Wall St. · 30 Oct 2026 19:06
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 56.56 EUR
- Market cap
- 55.8B
- Dividend yield
- 0.19%
- 5-year average yield
- 0.63%
- Payout ratio
- 162%
- Last dividend
- 0.1100 EUR · 27 Apr 2026
- Exchange
- XETRA
- Country
- Germany
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 27 Apr 2026 | 0.1100 EUR |
| 28 Apr 2025 | 0.1100 EUR |
| 29 Apr 2024 | 0.1100 EUR |
| 02 May 2023 | 2.4000 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 0.8 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 11.5 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 0.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.0 / 10 | — |
| Analysts How far the analysts' average target is from today's price. | 2.6 / 5 |
|
- Score capped at 50: three or more warnings
- The dividend is above the earnings (payout 162%)
- The last full year was a loss
- Revenue has fallen two years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 11.71× | Good | 14.16× |
| Price / book | 1.9× | Fair | 3.5× |
| Price / sales | 1.21× | Good | 3.33× |
| EV / EBITDA | 7.82× | Good | 11.19× |
| Free cash flow yield | 10.5% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 59.4% | Good | 54.9% |
| Operating margin | 16.5% | Good | 5.8% |
| Net margin | -3.2% | Weak | 1.1% |
| Return on equity | -4.6% | Weak | 4.2% |
| Return on assets | 4.3% | Fair | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -3.5% | Weak | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.34× | Fair | 0.4× |
| Net debt / EBITDA | 2.69× | Fair | 1.46× |
| Interest cover | 2.71× | Weak | 2.17× |
| Current ratio | 1.35× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 162.2% | Weak | 0% |
| Payout of free cash flow | 2.2% | Good | 28.7% |
| Payout of free cash flow (3 years) | 25.4% | Good | — |
| Dividend growth / year | -9.3% | Weak | 6.5% |
| Years of rising dividends | 0 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow BAYN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.